About
Technology
Issues
FAQ
Links
Official Page
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
